Quantum BioPharma Ltd.

CNSX:QNTM Stock Report

Market Cap: CA$6.6m

Quantum BioPharma Management

Management criteria checks 2/4

Quantum BioPharma's CEO is Zeeshan Saeed, appointed in Jul 2021, has a tenure of 3.08 years. total yearly compensation is $599.87K, comprised of 37.1% salary and 62.9% bonuses, including company stock and options. directly owns 2.65% of the company’s shares, worth CA$174.12K. The average tenure of the management team and the board of directors is 3.1 years and 2.9 years respectively.

Key information

Zeeshan Saeed

Chief executive officer

US$599.9k

Total compensation

CEO salary percentage37.1%
CEO tenure3.1yrs
CEO ownership2.7%
Management average tenure3.1yrs
Board average tenure2.9yrs

Recent management updates

Recent updates

We're Keeping An Eye On FSD Pharma's (CSE:HUGE) Cash Burn Rate

Apr 13
We're Keeping An Eye On FSD Pharma's (CSE:HUGE) Cash Burn Rate

We're Keeping An Eye On FSD Pharma's (CSE:HUGE) Cash Burn Rate

Dec 17
We're Keeping An Eye On FSD Pharma's (CSE:HUGE) Cash Burn Rate

Here's Why We're Watching FSD Pharma's (CSE:HUGE) Cash Burn Situation

Aug 25
Here's Why We're Watching FSD Pharma's (CSE:HUGE) Cash Burn Situation

How Many FSD Pharma Inc. (CSE:HUGE) Shares Did Insiders Buy, In The Last Year?

Feb 13
How Many FSD Pharma Inc. (CSE:HUGE) Shares Did Insiders Buy, In The Last Year?

CEO Compensation Analysis

How has Zeeshan Saeed's remuneration changed compared to Quantum BioPharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$7m

Mar 31 2024n/an/a

-US$10m

Dec 31 2023US$600kUS$223k

-US$18m

Sep 30 2023n/an/a

-US$23m

Jun 30 2023n/an/a

-US$29m

Mar 31 2023n/an/a

-US$31m

Dec 31 2022US$774kUS$239k

-US$27m

Sep 30 2022n/an/a

-US$27m

Jun 30 2022n/an/a

-US$25m

Mar 31 2022n/an/a

-US$30m

Dec 31 2021US$1mUS$225k

-US$34m

Sep 30 2021n/an/a

-US$32m

Jun 30 2021n/an/a

-US$39m

Mar 31 2021n/an/a

-US$30m

Dec 31 2020US$899kUS$212k

-US$28m

Sep 30 2020n/an/a

-US$36m

Jun 30 2020n/an/a

-US$35m

Mar 31 2020n/an/a

-US$41m

Dec 31 2019US$2mUS$249k

-US$34m

Sep 30 2019n/an/a

-US$38m

Jun 30 2019n/an/a

-US$25m

Mar 31 2019n/an/a

-US$16m

Dec 31 2018US$503kUS$183k

-US$17m

Compensation vs Market: Zeeshan's total compensation ($USD599.87K) is above average for companies of similar size in the Canadian market ($USD176.07K).

Compensation vs Earnings: Zeeshan's compensation has been consistent with company performance over the past year.

CEO

Zeeshan Saeed (54 yo)

3.1yrs

Tenure

US$599,873

Compensation

Mr. Zeeshan Saeed serves as Executive Co-Chairman at FSD Pharma Inc. since May 24, 2018 and serves as its President since July 27, 2021 and Chief Executive Officer since June 29, 2023. He serves as Co-Chai...

Leadership Team

NamePositionTenureCompensationOwnership
Zeeshan Saeed
Founder3.1yrsUS$599.87k2.65%
$ 174.1k
Anthony Durkacz
Founder & Executive Co-Chairman6.2yrsUS$599.87k1.2%
$ 79.0k
Nathan Coyle
Chief Financial Officer3.3yrsUS$178.21k0%
$ 0
Donal Carroll
Chief Operating Officer3yrsUS$602.87k0%
$ 0
Lakshmi Kotra
CEO of Lucid & Director2.9yrsUS$521.97k1.68%
$ 110.5k
Maryann Adesso
Corporate Secretaryno datano datano data
Randell Mack
President of FSD BioSciences3.4yrsno datano data
Andrzej Chruscinski
Vice President of Clinical & Scientific Affairs of Lucidno dataUS$110.30k0%
$ 0
Kevin Cassidy
Vice President of Quality-Lucidno dataUS$144.82kno data

3.1yrs

Average Tenure

48yo

Average Age

Experienced Management: QNTM's management team is considered experienced (3.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Zeeshan Saeed
Founder3.3yrsUS$599.87k2.65%
$ 174.1k
Anthony Durkacz
Founder & Executive Co-Chairman6.2yrsUS$599.87k1.2%
$ 79.0k
Lakshmi Kotra
CEO of Lucid & Director1.8yrsUS$521.97k1.68%
$ 110.5k
Daniele Piomelli
Member of Research & Clinical Advisory Board2.6yrsno datano data
Eleanor Fish
Member of Research & Clinical Advisory Board2.8yrsno datano data
Hance Clarke
Member of Research & Clinical Advisory Board2.9yrsno datano data
Eric Hoskins
Independent Director1.3yrsno datano data
Adnan Bashir
Independent Director3.2yrsUS$139.37k0.14%
$ 8.9k
Peter Stys
Member of Research & Clinical Advisory Board2.9yrsno datano data
Shannon Dunn
Member of Research & Clinical Advisory Board2.9yrsno datano data
Albert Wong
Member of Research & Clinical Advisory Board2.9yrsno datano data
Joga Gobburu
Member of Regulatory Advisory Board2.8yrsno datano data

2.9yrs

Average Tenure

54yo

Average Age

Experienced Board: QNTM's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.